|
Current issue
Archive
Online First
About the journal
Editorial board
Editorial office
Publisher
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
1/2020
vol. 19 abstract:
Review paper
An update on treatment options for interstitial cystitis
Simone Garzon
1
,
Antonio Simone Laganà
1
,
Jvan Casarin
1
,
Ricciarda Raffaelli
2
,
Antonella Cromi
1
,
Davide Sturla
1
,
Massimo Franchi
2
,
Fabio Ghezzi
1
Menopause Rev 2020; 19(1): 35-43
Online publish date: 2020/04/27
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Interstitial cystitis or bladder pain syndrome (IC/BPS) is a chronic pelvic pain syndrome related to the urinary bladder. The ideal treatment should match as much as possible with the pathophysiologic causes of the IC/BPS, but the scarcely available evidence limits this approach, with the majority of available treatments that are primarily targeted to the control of symptoms. The treatment strategies have traditionally focused on the bladder, which is considered the primary end-organ and source of pain. Nevertheless, the growing body of evidence suggests a multifaceted nature of the disease with systemic components. In general, guidelines recommend the personalized and progressive approach, that starts from the more conservative options and then advances toward more invasive and combined treatments. The behavioral changes represent the first and most conservative steps. They can be combined with oral medications or progressively with intravesical instillation of drugs, up to more invasive techniques in a combined way. Despite the multiple available options, the optimal treatment is not easy to be found. Only further investigation on the etiopathogenetic mechanisms, taking into account the differences among subgroups, and the interaction between central and peripherical factors may allow providing a real improvement in the treatment and management of these patients.
keywords:
urinary bladder, interstitial cystitis, pelvic pain, intravesical administration |
 |
